COVANCE INC
10-Q, EX-27, 2000-11-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: COVANCE INC, 10-Q, EX-10.B, 2000-11-14
Next: FOX FAMILY WORLDWIDE INC, 10-Q, 2000-11-14



<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
This schedule contains summary financial information extracted from the Covance
consolidated financial statements for the nine months ended September 30, 2000
and is qualified in its entirety by reference to such financial statements.
</LEGEND>
<CIK>                         0001023131
<NAME>                        Covance Inc.
<MULTIPLIER>                                         1
<CURRENCY>                                         USD

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                      18,835,000
<SECURITIES>                                         0
<RECEIVABLES>                              227,063,000
<ALLOWANCES>                                         0
<INVENTORY>                                 29,661,000
<CURRENT-ASSETS>                           343,504,000
<PP&E>                                     359,147,000
<DEPRECIATION>                              37,096,000
<TOTAL-ASSETS>                             773,468,000
<CURRENT-LIABILITIES>                      218,087,000
<BONDS>                                              0
                                0
                                          0
<COMMON>                                       597,000
<OTHER-SE>                                 272,849,000
<TOTAL-LIABILITY-AND-EQUITY>               773,468,000
<SALES>                                              0
<TOTAL-REVENUES>                           636,691,000
<CGS>                                      458,607,000
<TOTAL-COSTS>                              610,484,000
<OTHER-EXPENSES>                                38,000
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                          11,315,000
<INCOME-PRETAX>                             14,854,000
<INCOME-TAX>                                 5,749,000
<INCOME-CONTINUING>                          9,105,000
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 9,105,000
<EPS-BASIC>                                       0.16
<EPS-DILUTED>                                     0.16


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission